Auctus’ fast-growing tech investment, Gophr, surfaces on the green

|

Published 04-DEC-2018 12:42 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Auctus Alternative Investments (ASX:AVC) has updated the market on its investment in London-based last mile delivery business, Gophr.

Encouragingly, the Gophr business has continued on its strong growth trajectory, with sales for the calendar year to the end of November 2018 being approximately £2.6 million, up approximately 160% for the same period in the prior year.

Gophr is an Uber-style tech platform operating in the last mile delivery service market. It’s solving an addressable problem in this space — one which tends to be expensive and unreliable, and fraught with unpredictable demand.

Gophr’s solution, which automates traditional courier company tasks, drives efficiency and reduces costs, cutting through layers of logistics tech.

Notably, the global courier market is worth $250 billion a year, and is projected to grow to $343 billion by 2020.

AVC itself is a listed alternative investment fund manager with a focus on the rapidly growing global tech space. It has assembled a de-risked, diversified, high return portfolio spread across direct investments and in funds across Asia-Pacific, Europe and the US.

AVC currently owns 75% of Gophr. Gophr’s tier one customer base also continues to grow, providing AVC with confidence in Gophr’s business strategy and its solution for the complex last mile delivery problem.

Some of Gophr’s new customers in the last 12 months include:

  • Amazon
  • Net a Porter
  • UK Mail
  • Deliveroo
  • Selfridges & Co

In addition to these new customers, Gophr is expanding its service offering with its current customers to other major UK cities (outside of London) with the likes of:

  • Marks & Spencer
  • Hello Fresh
  • EVE Sleep
  • Farfetch

Discussions have progressed with several parties to take in external capital to help finance the business through its next phase of growth. AVC expects to update the market regarding this capital injection early in the new year, if not earlier.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X